BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With no room for error in the highly competitive ADC market an
 d no going back after you have selected your target\, it is vital that dr
 ug developers optimally triangulate the linker-payload\, target and indic
 ation to develop an ADC that can have the biggest impact on patients.\n\n
 Recent exciting developments in linker-payload technologies and clinical 
 efficacy in low-expressed tumors have propelled this conversation to the 
 forefront of mind. We are at the cusp of seeing clinical improvements on 
 previously validated targets\, witnessing success on targets where previo
 us ADCs have failed and engaging novel targets\, widening the application
  of ADCs beyond what was thought.\n\nThe 2nd ADC Target Selection Summit 
 will provide you an A-Z coverage of the key considerations that ADC devel
 opers are making when it comes to target selection including how to think
  about the payload and target holistically\, understand expression profil
 es\, and how proteomic and bioinformatic technologies can deepen our unde
 rstanding of targets going forward.\n\nDon't miss your one-stop shop to g
 ain exclusive insights as ADC enthusiasts with backgrounds in target ID a
 nd validation\, cancer biology and drug discovery come together to addres
 s core challenges in the target selection process.\n\nJoin 80+ peers from
  across the ADC landscape to transform your target selection strategies t
 o ensure you are maximizing the therapeutic window of your ADC and improv
 ing patients outcomes.\n
DTEND:20221208T170000
DTSTAMP:20260512T234700Z
DTSTART:20221206T090000
LOCATION:Hilton Boston Logan Airport\, One\, Hotel Drive\, Boston\, Massac
 husetts\, 02128\,
SEQUENCE:0
SUMMARY:With no room for error in the highly competitive ADC market and no
  going back after you have selected your target\, it is vital that drug d
 evelopers...
UID:839e123e-18fa-428b-a6ed-1f591a022533
END:VEVENT
END:VCALENDAR